Analysis of Flavin-Containing Monooxygenase 3 Genotype Data in Populations Administered the Anti-Schizophrenia Agent Olanzapine

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|2|2|100-114

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.2, Iss.2, 2008-04, pp. : 100-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flavin-containing monooxygenase 3 and human disease

By Motika Meike S   Zhang Jun   Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 831-845

Informa Healthcare

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria

By  

Current Drug Metabolism, Vol. 4, Iss. 2, 2003-04 ,pp. : 151-170

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives

By Hisamuddin Irfan M   Yang Vincent W  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 635-643

Future Medicine

Access to resources Recommend Favorite

Genetic Polymorphism of the Flavin-Containing Monooxygenase 3 (FMO3) Associated with Trimethylaminuria (Fish Odor Syndrome): Observations from Japanese Patients

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 487-491

Bentham Science Publishers

Access to resources Recommend Favorite